化学発光免疫測定分析装置の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年～2031年

化学発光免疫測定分析装置の世界市場規模は、2022年に54億1,000万米ドルと評価され、2023年の58億2,000万米ドルから2031年には103億7,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは7.5%で成長する見通しです。

慢性疾患や感染症患者の増加が、近年の世界の化学発光市場の成長をもたらしています。それにもかかわらず、様々な医学的疾患に関連するこれらのマーカーを同定する際の感度と特異性が非常に高いため、診断ラボで重要な役割を果たしています。化学発光イムノアッセイ分析装置を使えば、がん、心臓病、感染症などの病気を簡単に特定・追跡することができます。このため、健康管理、特に病気の早期発見が重視される現代社会では、正確で迅速な診断機器が必要とされ続けています。世界のヘルスケアコストの上昇と早期診断に対する意識の高まりにより、市場は開拓されつつあります。民間ヘルスケア機関は、政府に加えて、患者の結果をより良いものにするために先進的な診断技術を導入しています。

目次

エグゼクティブサマリー

• 市場概要
• 運命の輪

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の危機と限界

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主な投資の分析
• 主な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

化学発光免疫測定分析装置の世界市場：製品別

• 市場概要
• 全自動化学発光免疫測定装置および半自動化学発光免疫測定装置

化学発光免疫測定分析装置の世界市場：用途別

• 市場概要
• 感染症検査
• 内分泌系検査
• 心臓マーカー検査
• 腫瘍学検査
• 自己免疫疾患検査
• アレルギー検査
• その他

化学発光免疫測定分析装置の世界市場：エンドユーザー別

• 市場概要
• 病院
• 診断検査室
• 研究機関
• およびポイントオブケア検査

化学発光免疫測定分析装置の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Roche Diagnostics
• Abbott
• Siemens Healthcare
• Ortho Clinical Diagnostics
• Beckman Coulter
• Danaher（Beckman Coulter Life Sciences）
• Johnson & Johnson（Ortho-Clinical Diagnostics）
• DiaSorin
• Luminex Corporation
• Tosoh Bioscience
• Snibe Diagnostics
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Sysmex Corporation
• Hytest Ltd.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• ARCHITECT Diagnostics, Inc.
• Euroimmun Medizinische Labordiagnostika AG
• Mesan Pharma
• Abbott Point-of-Care Inc.

Global Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.41 billion in 2022 and is poised to grow from USD 5.82 billion in 2023 to USD 10.37 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The rise in chronic and infectious disease cases has led to a growth in the global chemiluminescence market in recent years. Nonetheless, because of their great sensitivity and specificity in identifying these markers associated with various medical disorders, they play a crucial role in diagnostic laboratories. Using chemiluminescence immunoassay analyzers, ailments like cancer, heart problems, and infectious infections can be easily identified or tracked. Because of this, there is a continuing need for accurate and quick diagnostic instruments in the modern society, which places a strong emphasis on health care, particularly the early detection of disease. The market is developing as a result of rising healthcare costs globally and rising awareness of early diagnosis. Private healthcare institutions are embracing advanced diagnostic technology, in addition to governments, toward enhancing patients' results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chemiluminescence Immunoassay Analyzers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chemiluminescence Immunoassay Analyzers Market Segmental Analysis

The global chemiluminescence immunoassay analyzers market is segmented into four major segments i.e. by product type, application, end user, and region. Based on type, it is divided into fully automated chemiluminescence immunoassay analyzers and semi-automated chemiluminescence immunoassay analyzers. Based on application, it is bifurcated as infectious disease testing, endocrine system testing, cardiac marker testing, oncology testing, autoimmune disease testing, allergy testing, and others. Based on end users it is segregated into hospitals, diagnostic laboratories, research institutes, and point-of-care testing. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Drivers of the Global Chemiluminescence Immunoassay Analyzers Market

More advanced tools are needed for accurate and timely diagnosis due to the increased prevalence of infectious and chronic diseases. Chemiluminescence immunoassay analyzers, which are frequently used in many diagnostics laboratories, are among those well-known brands. The global emphasis on illness prevention and early detection also contributes to the rise in demand for these analyzers. This is true since technical advancements are crucial, and regular upgrades raise the bar, improve accuracy, and so forth.

Restraints in the Global Chemiluminescence Immunoassay Analyzers Market

The substantial upfront and ongoing costs of purchasing and maintaining these advanced diagnostic devices are one of the primary market barriers. Smaller healthcare facilities and labs may find it more difficult to implement this cutting-edge equipment due to the significant initial cost. Furthermore, there may be a learning curve for medical practitioners due to the intricacy of these analyzers and their data interpretation procedures, which could slow down and reduce the accuracy of diagnoses. The market's growth may also be hampered by regional regulatory obstacles and compliance problems, which call for adherence to various standards and approval procedures.

Market Trends of the Global Chemiluminescence Immunoassay Analyzers Market

These analyzers' automated artificial intelligence (AI) integration speeds up diagnostic interpretations and laboratory turnaround times. It also makes administering tests easier, reduces the time needed to get results, and improves accuracy. Furthermore, there is a growing interest in expanding the applications of these devices to include hormone diagnostic research, microbial infection detection, and cancer diagnosis. In order to meet the expanding demand for PoC testing and remote diagnostics, manufacturers are also concentrating on creating more user-friendly and portable analyzers.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Chemiluminescence Immunoassay Analyzers Market by Product

• Market Overview
• Fully Automated Chemiluminescence Immunoassay Analyzers and Semi-Automated Chemiluminescence Immunoassay Analyzers

Global Chemiluminescence Immunoassay Analyzers Market by Application

• Market Overview
• Infectious Disease Testing
• Endocrine System Testing
• Cardiac Marker Testing
• Oncology Testing
• Autoimmune Disease Testing
• Allergy Testing
• and Others

Global Chemiluminescence Immunoassay Analyzers Market by End User

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• and Point-of-Care Testing

Global Chemiluminescence Immunoassay Analyzers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (Beckman Coulter Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ortho-Clinical Diagnostics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Snibe Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hytest Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARCHITECT Diagnostics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Euroimmun Medizinische Labordiagnostika AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesan Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Point-of-Care Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments